Bill number does not exist. Enter a vaild keyword.
Original
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Opposite
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Review in
Original Chamber
Passed Both
Chambers
Conf. Cmte
(if necessary)
To Governor
Title
Prescription Drug Affordability Board - Authority for Upper Payment Limits (Lowering Prescription Drug Costs for All Marylanders Now Act)
Sponsored by
Senators Gile and Feldman
Status
In the Senate - First Reading Finance
Analysis
Synopsis
Requiring the Prescription Drug Affordability Board, under certain circumstances, to establish a process for setting upper payment limits for all purchases and payor reimbursements of prescription drug products in the State that the Board determines have led or will lead to affordability challenges; authorizing the Board to reconsider an upper payment limit for a drug that becomes a current shortage; altering requirements related to the setting of upper payment limits by the Board; etc.
Committees
Original:
Finance
Details
Cross-filed with: HB0424
Bill File Type: Regular
Effective Date(s): October 1, 2025
Contingency - on a contingency described in Sec. 3 of the bill
Legislation History
Chamber
Senate
Calendar Date
1/16/2025
Legislative Date
1/16/2025
Action
First Reading Finance
Proceedings
Chamber Calendar Date Legislative Date Action Proceedings
Senate 1/16/2025 1/16/2025 First Reading Finance
Text - First - Prescription Drug Affordability Board - Authority for Upper Payment Limits (Lowering Prescription Drug Costs for All Marylanders Now Act)
Last Updated: 1/16/2025 3:23 PM
Click to return on the top page